Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

BRISTOL-MYERS SQUIBB COMPANY (BMY) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

BRISTOL-MYERS SQUIBB COMPANY (BMY), most recent 12 months reported: revenue $49.19B, net income $9.28B, free cash flow $11.44B. Latest balance sheet on file: liquid cash $11.07B, total debt $43.12B, net cash -$32.05B. From SEC filings. More on BRISTOL-MYERS SQUIBB COMPANY: Revenue · Profitability · Cash flow · Debt · Dividends Others in Pharmaceutical Preparations: ELI LILLY AND COMPANY · Merck & Co., Inc. · AbbVie Inc. · PFIZER INC · ABBOTT LABORATORIES · Universe Pharmaceuticals INC · TEVA PHARMACEUTICAL INDUSTRIES LIMITED · REGENERON PHARMACEUTICALS, INC.

Stock screener

Watchlist